Fig. 1From: First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort studyComparison of progression-free survival and overall survival in the two cohorts. Progression-free (A) and overall (B) survival of patients treated with HD-MTX or teniposide. MTX, high-dose methotrexate; TEN, teniposideBack to article page